|
Volumn 384, Issue 9942, 2014, Pages 474-475
|
Nicotinamide in Friedreich's ataxia: Useful or not?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
FRATAXIN;
HISTONE DEACETYLASE INHIBITOR;
NICOTINAMIDE;
HISTONE DEACETYLASE;
MESSENGER RNA;
AMINO ACID SEQUENCE;
CELL CULTURE;
CHROMATIN STRUCTURE;
DEACETYLATION;
DISEASE SEVERITY;
DORSAL ROOT;
EPIGENETICS;
FRATAXIN GENE;
FRIEDREICH ATAXIA;
GENE;
GENE EXPRESSION;
GENE SILENCING;
GENETIC TRANSCRIPTION;
HEART;
HETEROCHROMATIN;
HUMAN;
INTRON;
LONG TERM CARE;
NAUSEA AND VOMITING;
NONHUMAN;
NOTE;
PERIPHERAL BLOOD MONONUCLEAR CELL;
PRIORITY JOURNAL;
TREATMENT DURATION;
UPREGULATION;
CARDIOMYOPATHY;
CLINICAL FEATURE;
DRUG DOSE ESCALATION;
NAUSEA;
OPEN STUDY;
PHASE 1 CLINICAL TRIAL (TOPIC);
PHASE 2 CLINICAL TRIAL (TOPIC);
PHASE 3 CLINICAL TRIAL (TOPIC);
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SCOLIOSIS;
SINGLE DRUG DOSE;
VOMITING;
FEMALE;
FRIEDREICH ATAXIA;
HUMANS;
IRON-BINDING PROTEINS;
MALE;
NIACINAMIDE;
VITAMIN B COMPLEX;
|
EID: 84906318602
PISSN: 01406736
EISSN: 1474547X
Source Type: Journal
DOI: 10.1016/S0140-6736(14)60573-0 Document Type: Note |
Times cited : (7)
|
References (8)
|